Moderna to Present at Upcoming Conferences in March 2026

Rhea-AI Summary

Moderna (Nasdaq:MRNA) will present at two investor conferences in March 2026. Presentations are scheduled for TD Cowen 46th Annual Healthcare Conference on March 3, 2026 at 1:50 PM ET and Barclays 28th Annual Global Healthcare Conference on March 10, 2026 at 9:30 AM ET.

A live webcast will be available under Events and Presentations in the Investors section at investors.modernatx.com, with replays archived for at least 30 days after each presentation.

Key Figures

TD Cowen conference number: 46th TD Cowen date: March 3rd TD Cowen time: 1:50pm ET +5 more

8 metrics

TD Cowen conference number 46th TD Cowen 46th Annual Healthcare Conference

TD Cowen date March 3rd TD Cowen conference presentation date

TD Cowen time 1:50pm ET Scheduled presentation time at TD Cowen conference

Barclays conference number 28th Barclays 28th Annual Global Healthcare Conference

Barclays date March 10th Barclays conference presentation date

Barclays time 9:30am ET Scheduled presentation time at Barclays conference

Webcast replay period 30 days Minimum period replays will be archived on Moderna’s website

Price change 6.08% 24h move in MRNA prior to this news

Market Reality Check

Price: $46.60 Vol: Volume 13,089,214 is roug...

normal vol

$46.60 Last Close

Volume Volume 13,089,214 is roughly in line with the 13,484,965 share 20-day average. normal

Technical Price $46.60 is trading above the $29.53 200-day moving average.

Peers on Argus

MRNA gained 6.08% while only one scanned peer (ABVX) was up 3.31% and broader bi...

1 Up

MRNA gained 6.08% while only one scanned peer (ABVX) was up 3.31% and broader biotech peers showed mixed moves, pointing to a stock-specific move.

Historical Context

5 past events · Latest: Feb 18 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 18	Regulatory update	Positive	+6.1%	FDA accepted BLA for mRNA-1010 with PDUFA goal date set.
Feb 17	Regulatory approval	Positive	+4.0%	EU marketing authorization for COVID-19 vaccine mNEXSPIKE.
Feb 13	Earnings and guidance	Mixed	+5.3%	Q4/FY 2025 results with losses but cost cuts and 2026 growth plan.
Feb 10	Regulatory setback	Negative	+0.1%	FDA Refusal-to-File for mRNA-1010 BLA due to comparator choice.
Feb 10	Partnership deal	Positive	+0.1%	Five-year strategic agreement with Mexico for vaccines and tech transfer.

Pattern Detected

Recent news, including regulatory updates and earnings, has generally been followed by positive price moves, with even negative regulatory items seeing mildly positive reactions.

Recent Company History

Over recent weeks, Moderna reported multiple major updates, including an FDA Refusal-to-File for its flu vaccine on Feb 10, a strategic Mexico agreement, Q4 and FY 2025 results, and later an FDA decision to initiate review of its flu vaccine with a Aug 5, 2026 PDUFA goal date. These events tended to coincide with positive price reactions, suggesting investors focused on long-term pipeline and financial trajectory rather than single setbacks. Today’s conference participation notice fits into this ongoing investor communication cadence.

Market Pulse Summary

This announcement outlines Moderna’s participation in two March 2026 investor conferences, with pres...

Analysis

This announcement outlines Moderna’s participation in two March 2026 investor conferences, with presentations on March 3 and March 10 and webcast replays available for at least 30 days. In the context of recent regulatory updates, earnings, and strategic agreements, these events offer additional visibility into management’s messaging and priorities. Investors may watch for any new commentary on late-stage programs, cost structure, and capital allocation during these sessions.

AI-generated analysis. Not financial advice.

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

TD Cowen 46^th Annual Healthcare Conference, on Tuesday, March 3^rd at 1:50pm ET

Barclays 28^th Annual Global Healthcare Conference, on Tuesday, March 10^th at 9:30am ET

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Moderna (MRNA) present at the TD Cowen 46th Annual Healthcare Conference?

Moderna will present on March 3, 2026 at 1:50 PM ET. According to Moderna, the presentation will be available via a live webcast in the Investors section at investors.modernatx.com, with a replay archived for at least 30 days after the event.

What time is Moderna (MRNA) scheduled to speak at the Barclays 28th Annual Global Healthcare Conference?

Moderna is scheduled for March 10, 2026 at 9:30 AM ET. According to Moderna, investors can watch a live webcast under Events and Presentations on investors.modernatx.com and access a replay for at least 30 days after the presentation.

Where can investors watch Moderna (MRNA) webcasts for the March 2026 conferences?

Investors can watch live webcasts on Moderna's investor site at investors.modernatx.com under Events and Presentations. According to Moderna, each webcast will also have a replay archived on the site for at least 30 days following each presentation.

How long will Moderna (MRNA) keep replays of the March 2026 conference presentations available?

Moderna will archive replays for at least 30 days after each presentation. According to Moderna, the replays will be available in the Investors section at investors.modernatx.com under Events and Presentations for investor access.

Will Moderna (MRNA) provide slides or additional materials for the March 2026 conference presentations?

Moderna typically posts presentation materials in the Investors section, though availability varies by event. According to Moderna, live webcasts and archived replays will be on investors.modernatx.com; check Events and Presentations for any slides or supplemental documents after each session.